These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A constitutively active pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form. Cao Y, Gimpl G. Biochim Biophys Acta; 2001 Jul 09; 1548(1):139-51. PubMed ID: 11451447 [Abstract] [Full Text] [Related]
4. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC. Endocrinology; 1996 Jul 09; 137(7):2815-22. PubMed ID: 8770902 [Abstract] [Full Text] [Related]
5. The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. Cao YJ, Gimpl G, Fahrenholz F. Biochem Biophys Res Commun; 1995 Jul 17; 212(2):673-80. PubMed ID: 7626082 [Abstract] [Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C. Endocrinology; 2000 Mar 17; 141(3):1158-67. PubMed ID: 10698193 [Abstract] [Full Text] [Related]
7. Molecular structure analysis of the pituitary adenylate cyclase activating polypeptide type I receptor from pig brain. Cao YJ, Gimpl G, Fahrenholz F. Biochim Biophys Acta; 1994 Jul 21; 1222(3):432-40. PubMed ID: 8038212 [Abstract] [Full Text] [Related]
8. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain. Hu Z, Lelievre V, Chao A, Zhou X, Waschek JA. Endocrinology; 2000 Feb 21; 141(2):657-65. PubMed ID: 10650947 [Abstract] [Full Text] [Related]
10. Cyclic lactam analogues of ovine pituitary adenylate cyclase activating polypeptide (PACAP): discovery of potent type II receptor antagonists. Bitar KG, Somogyvari-Vigh A, Coy DH. Peptides; 1994 Feb 05; 15(3):461-6. PubMed ID: 7937320 [Abstract] [Full Text] [Related]
11. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21. Robberecht P, Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers-Piret MC, Vandermeers A, Christophe J. Mol Pharmacol; 1992 Aug 05; 42(2):347-55. PubMed ID: 1325033 [Abstract] [Full Text] [Related]
12. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation. Hashimoto H, Ogawa N, Hagihara N, Yamamoto K, Imanishi K, Nogi H, Nishino A, Fujita T, Matsuda T, Nagata S, Baba A. Mol Pharmacol; 1997 Jul 05; 52(1):128-35. PubMed ID: 9224822 [Abstract] [Full Text] [Related]
13. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP). Miyamoto Y, Habata Y, Ohtaki T, Masuda Y, Ogi K, Onda H, Fujino M. Biochim Biophys Acta; 1994 Aug 02; 1218(3):297-307. PubMed ID: 8049255 [Abstract] [Full Text] [Related]
14. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states. Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M. Mol Pharmacol; 1996 Dec 02; 50(6):1596-604. PubMed ID: 8967982 [Abstract] [Full Text] [Related]
15. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor. Wong AO, Leung MY, Shea WL, Tse LY, Chang JP, Chow BK. Endocrinology; 1998 Aug 02; 139(8):3465-79. PubMed ID: 9681497 [Abstract] [Full Text] [Related]
16. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Gourlet P, Vandermeers A, Vandermeers-Piret MC, Rathé J, De Neef P, Robberecht P. Eur J Pharmacol; 1995 Dec 04; 287(1):7-11. PubMed ID: 8666028 [Abstract] [Full Text] [Related]
17. cDNA cloning of a mouse pituitary adenylate cyclase-activating polypeptide receptor. Hashimoto H, Yamamoto K, Hagigara N, Ogawa N, Nishino A, Aino H, Nogi H, Imanishi K, Matsuda T, Baba A. Biochim Biophys Acta; 1996 Jun 11; 1281(2):129-33. PubMed ID: 8664310 [Abstract] [Full Text] [Related]
18. Characterization and purification of the solubilized pituitary adenylate-cyclase-activating polypeptide-1 receptor from porcine brain using a biotinylated ligand. Schäfer H, Schmidt WE. Eur J Biochem; 1993 Nov 01; 217(3):823-30. PubMed ID: 8223638 [Abstract] [Full Text] [Related]
19. Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors. Li M, Shioda S, Somogyvári-Vigh A, Onda H, Arimura A. Endocrine; 1997 Oct 01; 7(2):183-90. PubMed ID: 9549044 [Abstract] [Full Text] [Related]
20. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain. Schäfer H, Schwarzhoff R, Creutzfeldt W, Schmidt WE. Eur J Biochem; 1991 Dec 18; 202(3):951-8. PubMed ID: 1662620 [Abstract] [Full Text] [Related] Page: [Next] [New Search]